Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.53 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2047412 | 0.98 | GSR (0.55) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL1010091 | 0.92 | GSR (0.47) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL23515277 | 0.85 | GSR (0.50) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL7743513 | 0.85 | GSR (0.44) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL4204273 | 0.84 | GSR (0.57) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL23457451 | 0.84 | GSR (0.57) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL4270854 | 0.82 | GSR (0.45) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL2230619 | 0.82 | GSR (0.48) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL28063000 | 0.82 | GSR (0.48) | GSRGNAI3GNAO1GNAI1CPB2 | |
| SCHEMBL25186742 | 0.82 | GSR (0.48) | GSRGNAI3GNAO1GNAI1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0462669-B1 | Amine enriched proteins | JOHNSON & JOHNSON CLIN DIAG (US) | 1996-11-13 | — | — | EP | claimed |
| EP-0462669-A2 | Amine enriched proteins | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-12-27 | — | — | EP | claimed |
| EP-0462669-B1 | Amine enriched proteins | JOHNSON & JOHNSON CLIN DIAG (US) | 1996-11-13 | — | — | EP | disclosed |
| US-5162219-A | Reacting with amide bond forming agent in presence of polyamine; labels in immunoassay | EASTMAN KODAK COMPANY (US) | 1992-11-10 | — | — | US | disclosed |
| EP-0462669-A2 | Amine enriched proteins | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1991-12-27 | — | — | EP | disclosed |